| 1 |
Kizilaslan EZ, Ghadge NM, Martinez A, Bass M, Winayak R, Mathew M, Amin R, Khan M, Kizilbash N. Acute Intermittent Porphyria’s Symptoms and Management: A Narrative Review. Cureus 2023. [DOI: 10.7759/cureus.36058] [Reference Citation Analysis]
|
| 2 |
Randjelovic M, Stojanovic M, Radeka J, Vasilijic M, Jankovic R. Anesthetic implications in porphyrias. Front Anesthesiol 2023;2. [DOI: 10.3389/fanes.2023.1149949] [Reference Citation Analysis]
|
| 3 |
Sreevalsakumar S, Nair C, Vellingiri B, Valsala Gopalakrishnan A. Porphyria. Genetic Syndromes 2023. [DOI: 10.1007/978-3-319-66816-1_1784-1] [Reference Citation Analysis]
|
| 4 |
Ma CD, Faust D, Bonkovsky HL. Idiosyncratic drug-induced liver injury caused by givosiran in a patient with acute intermittent porphyria. Mol Genet Metab Rep 2023;34:100946. [PMID: 36578356 DOI: 10.1016/j.ymgmr.2022.100946] [Reference Citation Analysis]
|
| 5 |
Yehya A. Interplay between Pharmacokinetics and Pharmacogenomics. Dosage Forms [Working Title] 2022. [DOI: 10.5772/intechopen.108407] [Reference Citation Analysis]
|
| 6 |
Ma CD, Bonkovsky HL. Elagolix is porphyrogenic and may induce porphyric attacks in patients with the acute hepatic porphyrias. Mol Genet Metab Rep 2022;33:100915. [PMID: 36105850 DOI: 10.1016/j.ymgmr.2022.100915] [Reference Citation Analysis]
|
| 7 |
Pashkov EA, Korotysheva MO, Pak AV, Faizuloev EB, Sidorov AV, Poddubikov AV, Bystritskaya EP, Dronina YE, Solntseva VK, Zaiceva TA, Pashkov EP, Bykov AS, Svitich OA, Zverev VV. Investigation of the anti-influenza activity of siRNA complexes against the cellular genes <i>FLT4, Nup98</i>, and <i>Nup205 in vitro</i>. Fine Chem Technol 2022;17:140-151. [DOI: 10.32362/2410-6593-2022-17-2-140-151] [Reference Citation Analysis]
|
| 8 |
Ventura P, Ricci A. Givosiran for the treatment of acute hepatic porphyria. Expert Review of Clinical Pharmacology. [DOI: 10.1080/17512433.2022.2075848] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 9 |
Pashkov EA, Sechenov University,, Korchevaya ER, Faizuloev EB, Pashkov EP, Zaiceva TA, Rtishchev AA, Poddubikov AV, Svitich OA, Zverev VV, I. Mechnikov Research Institute of Vaccines and Sera, I. Mechnikov Research Institute of Vaccines and Sera, Sechenov University, Moscow, Russia, Sechenov University, Moscow,, I. Mechnikov Research Institute of Vaccines and Sera, Moscow,, I. Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia, I. Mechnikov Research Institute of Vaccines and Sera, Sechenov University, Moscow, Russia. Creation of a model for studying the antiviral effect of small interfering RNAs in vitro. Sanitary Doctor 2022. [DOI: 10.33920/med-08-2201-07] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
de Souza PVS, Badia BML, Farias IB, Pinto WBVR, Oliveira ASB. Acute Hepatic Porphyria: Pathophysiological Basis of Neuromuscular Manifestations. Front Neurosci 2021;15:715523. [PMID: 34646118 DOI: 10.3389/fnins.2021.715523] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
